Guidelines for Managing Gastroesophageal Reflux Disease (GERD)

Initial Management

The American College of Gastroenterology recommends initiating a 4-8 week trial of standard-dose proton pump inhibitor (PPI) therapy for patients with typical GERD symptoms, taken 30-60 minutes before the first meal of the day without requiring initial endoscopy 1, 2.
PPIs are the cornerstone of GERD treatment and should be the first-line pharmacologic therapy, as they are superior to H2-receptor antagonists and placebo for symptom relief and healing of erosive esophagitis 3, 2.

Weight loss is recommended for all overweight or obese patients, as this can significantly improve symptoms and is one of the few lifestyle interventions with strong supporting evidence 1, 3, 2.
Elevate the head of the bed by 6-8 inches for patients experiencing nighttime symptoms or regurgitation when lying down 1, 3, 2.
Avoid lying down for 2-3 hours after meals to reduce esophageal acid exposure 1, 3, 2.

Increase to twice-daily PPI dosing (before breakfast and dinner) to provide more complete acid suppression for patients with persistent symptoms despite standard-dose PPI therapy 1, 3, 2.
Consider adding an H2-receptor antagonist at bedtime for breakthrough nighttime symptoms, though tachyphylaxis may develop with continued use 1, 2.

Verify proper PPI timing and adherence before concluding treatment failure—PPIs must be taken 30-60 minutes before meals 1, 2.
Perform prolonged wireless pH monitoring off PPI therapy in patients without erosive disease on endoscopy to objectively confirm GERD diagnosis 1, 2.

Implement a strict antireflux diet limiting fat to ≤45g per day and eliminating coffee, tea, soda, chocolate, mints, citrus products (including tomatoes), and alcohol for patients with chronic cough or other extraesophageal symptoms attributed to GERD 4, 5, 1.
Prescribe twice-daily PPI therapy combined with prokinetic therapy for patients with extraesophageal GERD symptoms 4, 5, 1.
Allow 1-3 months for response assessment, as extraesophageal symptoms respond more slowly than typical GERD symptoms 4, 5.

Taper PPI to the lowest effective dose to minimize potential long-term risks while maintaining symptom control after achieving symptom control 1, 3, 2.
Periodically reassess the need for continued PPI therapy, as some patients may be able to discontinue or reduce dosing 1, 3, 2.